These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 29348964)

  • 21. The Neurobiology and Age-Related Prevalence of the ε4 Allele of Apolipoprotein E in Alzheimer's Disease Cohorts.
    Heffernan AL; Chidgey C; Peng P; Masters CL; Roberts BR
    J Mol Neurosci; 2016 Nov; 60(3):316-324. PubMed ID: 27498201
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The CDC2 I-G-T haplotype associated with the APOE epsilon4 allele increases the risk of sporadic Alzheimer's disease in Sicily.
    Bosco P; Caraci F; Copani A; Spada RS; Sortino MA; Salluzzo R; Salemi M; Nicoletti F; Ferri R
    Neurosci Lett; 2007 Jun; 419(3):195-8. PubMed ID: 17498878
    [TBL] [Abstract][Full Text] [Related]  

  • 23.
    Chemparathy A; Guen YL; Chen S; Lee EG; Leong L; Gorzynski J; Xu G; Belloy M; Kasireddy N; Tauber AP; Williams K; Stewart I; Wingo T; Lah J; Jayadev S; Hales C; Peskind E; Child DD; Keene CD; Cong L; Ashley E; Yu CE; Greicius MD
    medRxiv; 2023 Jul; ():. PubMed ID: 37547016
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [ACT/AA polymorphism could duplicate the APOE*epsilon4-associated Alzheimer's disease risk].
    Hernández-Charro B; Moreno S; Valiente A; Manubens JM; Villar MD; Ramos-Arroyo MA
    Med Clin (Barc); 2004 Sep; 123(7):251-4. PubMed ID: 15482730
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Apolipoprotein E epsilon4 allele frequency in vascular dementia.
    Davidson Y; Gibbons L; Purandare N; Byrne J; Hardicre J; Wren J; Payton A; Pendleton N; Horan M; Burns A; Mann DM
    Dement Geriatr Cogn Disord; 2006; 22(1):15-9. PubMed ID: 16645276
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Further evidence for a synergistic association between APOE epsilon4 and BCHE-K in confirmed Alzheimer's disease.
    Wiebusch H; Poirier J; Sévigny P; Schappert K
    Hum Genet; 1999 Feb; 104(2):158-63. PubMed ID: 10190327
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Interplay between the APOE Genotype and Possible Plasma Biomarkers in Alzheimer's Disease.
    Zverova M; Kitzlerova E; Fisar Z; Jirak R; Hroudova J; Benakova H; Lelkova P; Martasek P; Raboch J
    Curr Alzheimer Res; 2018; 15(10):938-950. PubMed ID: 29852871
    [TBL] [Abstract][Full Text] [Related]  

  • 28. ApoE -491A/T promoter polymorphism is not an independent risk factor, but associated with the epsilon4 allele in Hungarian Alzheimer's dementia population.
    Juhász A; Palotás A; Janka Z; Rimanóczy A; Palotás M; Bódi N; Boda K; Zana M; Vincze G; Kálmán J
    Neurochem Res; 2005 May; 30(5):591-6. PubMed ID: 16176061
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Apolipoprotein E genotype in sporadic early- and late-onset Alzheimer's disease.
    Masullo C; Daniele A; Seripa D; Filippini V; Gravina C; Carbone G; Gainotti G; Fazio VM
    Dement Geriatr Cogn Disord; 1998; 9(3):121-5. PubMed ID: 9621997
    [TBL] [Abstract][Full Text] [Related]  

  • 30. No association between alpha-1-antichymotrypsin polymorphism and Alzheimer's disease in Koreans.
    Kim KW; Jhoo JH; Lee KU; Lee DY; Lee JH; Youn JY; Lee BJ; Han SH; Woo JI
    Am J Med Genet; 2000 Apr; 91(5):355-8. PubMed ID: 10766998
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Deficiency in mitochondrial aldehyde dehydrogenase increases the risk for late-onset Alzheimer's disease in the Japanese population.
    Kamino K; Nagasaka K; Imagawa M; Yamamoto H; Yoneda H; Ueki A; Kitamura S; Namekata K; Miki T; Ohta S
    Biochem Biophys Res Commun; 2000 Jun; 273(1):192-6. PubMed ID: 10873585
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Genetic Interaction of
    Chang YT; Kazui H; Ikeda M; Huang CW; Huang SH; Hsu SW; Chang WN; Chang CC
    Aging Dis; 2019 Jun; 10(3):510-519. PubMed ID: 31164996
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Predictive value of APOE-ε4 allele for progression from MCI to AD-type dementia: a meta-analysis.
    Elias-Sonnenschein LS; Viechtbauer W; Ramakers IH; Verhey FR; Visser PJ
    J Neurol Neurosurg Psychiatry; 2011 Oct; 82(10):1149-56. PubMed ID: 21493755
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of APOE-ε4 allele load on brain morphology in a cohort of middle-aged healthy individuals with enriched genetic risk for Alzheimer's disease.
    Cacciaglia R; Molinuevo JL; Falcón C; Brugulat-Serrat A; Sánchez-Benavides G; Gramunt N; Esteller M; Morán S; Minguillón C; Fauria K; Gispert JD;
    Alzheimers Dement; 2018 Jul; 14(7):902-912. PubMed ID: 29605385
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Genetic risk for Alzheimer's disease influences neuropathology via multiple biological pathways.
    Hannon E; Shireby GL; Brookes K; Attems J; Sims R; Cairns NJ; Love S; Thomas AJ; Morgan K; Francis PT; Mill J
    Brain Commun; 2020; 2(2):fcaa167. PubMed ID: 33376986
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The apolipoprotein E epsilon4 allele causes a faster decline of cognitive performances in Down's syndrome subjects.
    Del Bo R; Comi GP; Bresolin N; Castelli E; Conti E; Degiuli A; Ausenda CD; Scarlato G
    J Neurol Sci; 1997 Jan; 145(1):87-91. PubMed ID: 9073034
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Age-dependent effects of APOE ε4 in preclinical Alzheimer's disease.
    Bonham LW; Geier EG; Fan CC; Leong JK; Besser L; Kukull WA; Kornak J; Andreassen OA; Schellenberg GD; Rosen HJ; Dillon WP; Hess CP; Miller BL; Dale AM; Desikan RS; Yokoyama JS
    Ann Clin Transl Neurol; 2016 Sep; 3(9):668-77. PubMed ID: 27648456
    [TBL] [Abstract][Full Text] [Related]  

  • 38. APOE epsilon4 and Alzheimer's disease: positive association in a Colombian clinical series and review of the Latin-American studies.
    Jacquier M; Arango D; Villareal E; Torres O; Serrano ML; Cruts M; Montañes P; Cano C; Rodriguez MN; Serneels S; Van Broeckhoven C
    Arq Neuropsiquiatr; 2001 Mar; 59(1):11-7. PubMed ID: 11299424
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inverse effect of the APOE epsilon4 allele in late- and early-onset Alzheimer's disease.
    De Luca V; Orfei MD; Gaudenzi S; Caltagirone C; Spalletta G
    Eur Arch Psychiatry Clin Neurosci; 2016 Oct; 266(7):599-606. PubMed ID: 26714935
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Apolipoprotein E epsilon4 allele and familial aggregation of Alzheimer disease.
    Martinez M; Campion D; Brice A; Hannequin D; Dubois B; Didierjean O; Michon A; Thomas-Anterion C; Puel M; Frebourg T; Agid Y; Clerget-Darpoux F
    Arch Neurol; 1998 Jun; 55(6):810-6. PubMed ID: 9626772
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.